| Product Code: ETC6003236 | Publication Date: Sep 2024 | Updated Date: Oct 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Afghanistan CNV (Choroidal NeoVascularization) Market Overview |
3.1 Afghanistan Country Macro Economic Indicators |
3.2 Afghanistan CNV (Choroidal NeoVascularization) Market Revenues & Volume, 2021 & 2031F |
3.3 Afghanistan CNV (Choroidal NeoVascularization) Market - Industry Life Cycle |
3.4 Afghanistan CNV (Choroidal NeoVascularization) Market - Porter's Five Forces |
3.5 Afghanistan CNV (Choroidal NeoVascularization) Market Revenues & Volume Share, By Diagnosis, 2021 & 2031F |
3.6 Afghanistan CNV (Choroidal NeoVascularization) Market Revenues & Volume Share, By Treatment, 2021 & 2031F |
3.7 Afghanistan CNV (Choroidal NeoVascularization) Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
3.8 Afghanistan CNV (Choroidal NeoVascularization) Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Afghanistan CNV (Choroidal NeoVascularization) Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of age-related macular degeneration (AMD) in Afghanistan |
4.2.2 Growing awareness and adoption of advanced treatment options for CNV |
4.2.3 Government initiatives to improve healthcare infrastructure and access to eye care services |
4.3 Market Restraints |
4.3.1 Limited access to specialized healthcare services in remote areas of Afghanistan |
4.3.2 High cost associated with CNV treatment and medications |
4.3.3 Lack of skilled ophthalmologists and healthcare professionals in the country |
5 Afghanistan CNV (Choroidal NeoVascularization) Market Trends |
6 Afghanistan CNV (Choroidal NeoVascularization) Market, By Types |
6.1 Afghanistan CNV (Choroidal NeoVascularization) Market, By Diagnosis |
6.1.1 Overview and Analysis |
6.1.2 Afghanistan CNV (Choroidal NeoVascularization) Market Revenues & Volume, By Diagnosis, 2021- 2031F |
6.1.3 Afghanistan CNV (Choroidal NeoVascularization) Market Revenues & Volume, By Fluorescein AngiographyOptical Coherence Tomography, 2021- 2031F |
6.1.4 Afghanistan CNV (Choroidal NeoVascularization) Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Afghanistan CNV (Choroidal NeoVascularization) Market, By Treatment |
6.2.1 Overview and Analysis |
6.2.2 Afghanistan CNV (Choroidal NeoVascularization) Market Revenues & Volume, By Anti-VEGF, 2021- 2031F |
6.2.3 Afghanistan CNV (Choroidal NeoVascularization) Market Revenues & Volume, By Photodynamic Therapy, 2021- 2031F |
6.2.4 Afghanistan CNV (Choroidal NeoVascularization) Market Revenues & Volume, By Thermal Laser, 2021- 2031F |
6.2.5 Afghanistan CNV (Choroidal NeoVascularization) Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Afghanistan CNV (Choroidal NeoVascularization) Market, By End-Users |
6.3.1 Overview and Analysis |
6.3.2 Afghanistan CNV (Choroidal NeoVascularization) Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.3.3 Afghanistan CNV (Choroidal NeoVascularization) Market Revenues & Volume, By Homecare, 2021- 2031F |
6.3.4 Afghanistan CNV (Choroidal NeoVascularization) Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
6.3.5 Afghanistan CNV (Choroidal NeoVascularization) Market Revenues & Volume, By Others, 2021- 2031F |
6.4 Afghanistan CNV (Choroidal NeoVascularization) Market, By Distribution Channel |
6.4.1 Overview and Analysis |
6.4.2 Afghanistan CNV (Choroidal NeoVascularization) Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.4.3 Afghanistan CNV (Choroidal NeoVascularization) Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
6.4.4 Afghanistan CNV (Choroidal NeoVascularization) Market Revenues & Volume, By online Pharmacies, 2021- 2031F |
6.4.5 Afghanistan CNV (Choroidal NeoVascularization) Market Revenues & Volume, By Others, 2021- 2031F |
7 Afghanistan CNV (Choroidal NeoVascularization) Market Import-Export Trade Statistics |
7.1 Afghanistan CNV (Choroidal NeoVascularization) Market Export to Major Countries |
7.2 Afghanistan CNV (Choroidal NeoVascularization) Market Imports from Major Countries |
8 Afghanistan CNV (Choroidal NeoVascularization) Market Key Performance Indicators |
8.1 Number of patients diagnosed with CNV annually |
8.2 Adoption rate of advanced treatment options for CNV |
8.3 Percentage increase in government healthcare expenditure on eye care services |
8.4 Number of outreach programs and awareness campaigns conducted for CNV |
8.5 Rate of successful outcomes in CNV treatment |
9 Afghanistan CNV (Choroidal NeoVascularization) Market - Opportunity Assessment |
9.1 Afghanistan CNV (Choroidal NeoVascularization) Market Opportunity Assessment, By Diagnosis, 2021 & 2031F |
9.2 Afghanistan CNV (Choroidal NeoVascularization) Market Opportunity Assessment, By Treatment, 2021 & 2031F |
9.3 Afghanistan CNV (Choroidal NeoVascularization) Market Opportunity Assessment, By End-Users, 2021 & 2031F |
9.4 Afghanistan CNV (Choroidal NeoVascularization) Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Afghanistan CNV (Choroidal NeoVascularization) Market - Competitive Landscape |
10.1 Afghanistan CNV (Choroidal NeoVascularization) Market Revenue Share, By Companies, 2024 |
10.2 Afghanistan CNV (Choroidal NeoVascularization) Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here